Skip to main content

Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day

Amsterdam, February 10, 2026 Full year and Q4 highlightsComparable order intake growth 6% in 2025; up 7% in Q4 Group sales of EUR 17.8 billion in 2025, EUR 5.1 billion in Q4; comparable sales growth 2% in 2025, 7% in Q4 Income from operations was EUR 1,424 million in 2025; EUR 540 million in Q4 Adjusted EBITA margin increased 80 basis points to 12.3% of sales in 2025; up 160 basis points to 15.1% in Q4 Operating cash flow of EUR 1,172 million in 2025; EUR 1,391 million in Q4 Free cash flow of EUR 512 million in 2025; EUR 1,200 million in Q4 Productivity savings of EUR 0.8 billion in 2025; delivered 2023-2025 target of EUR 2.5 billion Proposed 2025 dividend of EUR 0.85 per share, in shares or cash at the option of the shareholder Outlook for 2026 publishedCapital Markets DayPhilips sets out plan to drive profitable growth to deliver...

Continue reading

SalMar – Strong operational performance with record‑high harvest volume and lower cost level

With a lower cost level in the value chain and rising market prices, the result for the fourth quarter increased significantly compared with earlier quarters in 2025 and same quarter in 2024. In 2025, SalMar also reached a milestone where the Group, including associated companies, for the first time exceeded 300,000 tonnes harvested in a single year (300,900 tonnes). Operational EBIT for Norway was NOK 1,843 million in the fourth quarter of 2025. The harvest volume was 80,300 tonnes, and operational EBIT per kg was NOK 23.0. For the Group, operational EBIT was NOK 1,834 million in the fourth quarter of 2025. The harvest volume was 84,100 tonnes, and operational EBIT per kg was NOK 21.8. Continued strong operational and biological performance in Norway, with lower costs in the value chain. Reduced contribution from Sales & Industry...

Continue reading

onsemi Reports Fourth Quarter and Full Year 2025 Results

Returned $1.4 billion of 2025 Free Cash Flow through share repurchases SCOTTSDALE, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) — onsemi (the “Company”) (Nasdaq: ON) today announced its fourth quarter and fiscal year 2025 results: Results Highlights:Fourth quarter revenue of $1,530 million Fourth quarter GAAP gross margin and non-GAAP gross margin of 36.0% and 38.2%, respectively Fourth quarter GAAP operating margin and non-GAAP operating margin of 13.1% and 19.8%, respectively Fourth quarter GAAP diluted earnings per share and non-GAAP diluted earnings per share of $0.45 and $0.64, respectively 2025 cash from operations of $1.8 billion and free cash flow of $1.4 billion, achieving record high free cash flow margin of 24%“We remained disciplined in our execution and met expectations in the fourth quarter as we saw increasing signs...

Continue reading

DLH Reports Fiscal 2026 First Quarter Results

ATLANTA, Feb. 09, 2026 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science research and development, today announced financial results for its fiscal first quarter ended December 31, 2025. Q1 Highlights:Revenue variance from prior year period reflects the transition of certain programs to small-business set-aside contractors Adjusted EBITDA of $6.5 million, or 9.5% of revenue, benefitting from the Company’s initiatives to reduce costs and streamline operations Operating cash usage of $4.8 million, reflecting normal first quarter patterns and working capital use; an improvement of almost $7 million year-over-year Debt rose modestly due to short-term working capital needs; Company remains...

Continue reading

Prospect Capital Announces Financial Results for December 2025

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced financial results for our fiscal quarter ended December 31, 2025. FINANCIAL RESULTSAll amounts in $000’s exceptper share amounts (on weighted average basis for period numbers) Quarter Ended Quarter Ended Quarter Ended  December 31, 2025 September 30, 2025 December 31, 2024       Net Investment Income (“NII”) $90,888 $79,350 $86,431NII per Common Share $0.19 $0.17 $0.20Interest as % of Total Investment Income 84.7% 96.7% 91.0%       Net Income (Loss) Applicable to Common Shareholders $(6,576) $48,087 $(30,993)Net Income (Loss) per Common Share $(0.01) $0.10 $(0.07)       Distributions to Common Shareholders $63,894 $62,393 $65,554Distributions per Common Share $0.135 $0.135 $0.15Cumulative...

Continue reading

Viper Networks Releases Annual Financial Statements

TROY, Mich., Feb. 09, 2026 (GLOBE NEWSWIRE) — Viper Networks (OTCID: VPER) released its annual financial statements for the fiscal year ended December 31, 2025. The company continued to improve its quarter-over-quarter performance without increasing liabilities, increased cash and positive EBITDA. Revenues for the year increased to $5.546 million, increasing from $936 thousand in the same period during 2024. EBITDA increased to $199,197, increasing from ($218,035) in the same period in 2024. The increase was due to the acquisition of the telecommunications subsidiaries now known as 0Wire Communications, LLC, and 0Wire Wholesale, LLC, and their subsidiaries. The subsidiaries generated $3,280 million in annualized revenue during the most recent annual reporting period before the acquisition by Viper, representing an increase of 69%,...

Continue reading

Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

Company to host a webcast today at 8:30 am Eastern Time NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today reported financial results for its first quarter of fiscal 2026. “As we have entered 2026, we continue to progress our innovative clinical pipeline with particular focus on our lead candidate, oral blarcamesine in early Alzheimer’s disease. Based on our commitment to improving the lives of patients with neurological disorders, we remain excited about the therapeutic...

Continue reading

Aeries Technology Reports Third Quarter Fiscal 2026 Results; Increases FY26 Adjusted EBITDA Guidance; Issues FY27 Outlook

Margin Expansion, Operating Leverage and Multi-Year GCC Momentum Drive Increased Visibility NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT) (“Aeries” or the “Company”), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced financial results for its third quarter of fiscal 2026, ended December 31, 2025. Based on performance through the third quarter and continued execution momentum, Aeries is increasing the current full-year fiscal 2026 adjusted EBITDA guidance to a range of $7 million to $8 million, compared to the prior guidance of $6 million to $8 million. For fiscal 2027, which runs from April 2026 through March 2027, and based on our current portfolio of signed contracts and active program expansions already underway, Aeries expects...

Continue reading

American Battery Technology Company Announces Record Breaking Revenue as it Ramps Manufacturing of Critical Minerals and Publishes its Second Quarter Fiscal 2026 Financial Results

Quarterly revenue increases over 1,300% YOY while total operating expenses decrease 24% YOY, as company continues to ramp and streamline operational efficienciesAMERICAN BATTERY TECHNOLOGY COMPANYFY 2026, Second Quarter Unaudited Condensed Consolidated Statements of OperationsAMERICAN BATTERY TECHNOLOGY COMPANYFY 2026, Second Quarter Unaudited Condensed Consolidated Balance SheetsReno, Nev., Feb. 06, 2026 (GLOBE NEWSWIRE) — American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated battery critical minerals company that is commercializing its internally-developed technologies for both primary critical minerals manufacturing and secondary critical mineral recycling, released its financial results for the second quarter of its fiscal year (FY) 2026, which ended on December 31, 2025. The company...

Continue reading

Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026

NEW ALBANY, Ohio, Feb. 06, 2026 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, March 4, 2026, at 8:30 a.m. ET. A press release detailing the company’s fourth quarter and full year results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the fourth quarter and full year results will be available on the company’s website at approximately 7:30 a.m. ET.Conference Call: To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.   Webcast: To listen to a live webcast of the call, please visit corporate.abercrombie.com/investors/news-and-events/events/ and click the link to the webcast.   Replay: A...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.